American Heart Association Expands CKM Education to Bridge Science and Patient Care in Texas

Texas clinicians now have access to a suite of new educational resources from the American Heart Association designed to help them apply the first-ever cardiovascular-kidney-metabolic (CKM) syndrome guideline in everyday practice. The expanded portfolio, announced this week, includes micro-learnings, podcasts, on-demand videos, apps, and toolkits, all aimed at improving care for patients with overlapping heart, kidney, and metabolic conditions such as Type 2 diabetes and obesity.

The initiative matters because these interconnected conditions are increasingly common and costly to treat when managed in isolation. By equipping physicians, nurses, pharmacists, and other team members with practical, evidence-based tools, the Association hopes to standardize care and reduce the burden on Texas’s healthcare system. “CKM syndrome challenges clinicians to look beyond a single condition and consider how cardiovascular, kidney and metabolic health influence one another,” said Dr. Ambar Kulshreshtha, a family practice physician and professor at Emory School of Medicine. “These educational resources support a range of learning styles and busy schedules, giving care team members practical ways to build knowledge, stay current with the latest evidence and apply recommendations.”

The resources are housed on the Association’s CKM Health for Professionals site. For time-pressed clinicians, Micro-Learnings (15 minutes or less) offer short videos on topics like measuring waist circumference and highlights from the 2026 guideline. Longer formats include podcasts and a virtual summit, CKM Syndrome Guideline Unpacked: A Unified Approach for Interdisciplinary Prevention & Care, featuring insights from the guideline writing committee.

Point-of-care tools are also part of the expansion. The American Heart Association Predicting Risk of cardiovascular disease EVENTsTM (PREVENT) Online Calculator estimates 10- and 30-year cardiovascular disease risk by integrating cardiovascular, kidney, and metabolic measures. A QuickStart guide and the Guidelines-on-the-Go app further support implementation. Many of these offerings are part of the Association’s Cardiovascular-Kidney-Metabolic Health Initiative™, supported by sponsors including Novo Nordisk, Boehringer Ingelheim, Novartis, Bayer, and DaVita.

For Texas businesses, the implications are twofold. First, improved CKM care can help control healthcare costs that weigh on employers and employees. Second, the emphasis on interdisciplinary prevention aligns with the state’s growing focus on value-based care. As the Association notes, the guideline was issued to address the rising prevalence of CKM syndrome, and education is key to turning that science into action. Clinicians can follow updates via @HeartNews on X, and more information is available at heart.org and stroke.org. The original release can be viewed on www.newmediawire.com.